Cargando…

Myocarditis Following COVID-19 Vaccination: A Systematic Review

COVID-19 vaccination has significantly reduced both the morbidity and mortality rates associated with SARS-CoV-2 infection. Vaccines, especially mRNA vaccines, have been proposed in several studies to complicate viral myocarditis. Thus, our systematic and meta-analysis review aims to further investi...

Descripción completa

Detalles Bibliográficos
Autores principales: Shaheen, Nour, Ramadan, Abdelraouf, Shaheen, Ahmed, Elmasry, Mohamed, Swed, Sarya, Hafez, Wael, Wael, Muhannad
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Cureus 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10203748/
https://www.ncbi.nlm.nih.gov/pubmed/37223162
http://dx.doi.org/10.7759/cureus.37999
_version_ 1785045697501855744
author Shaheen, Nour
Ramadan, Abdelraouf
Shaheen, Ahmed
Elmasry, Mohamed
Swed, Sarya
Hafez, Wael
Wael, Muhannad
author_facet Shaheen, Nour
Ramadan, Abdelraouf
Shaheen, Ahmed
Elmasry, Mohamed
Swed, Sarya
Hafez, Wael
Wael, Muhannad
author_sort Shaheen, Nour
collection PubMed
description COVID-19 vaccination has significantly reduced both the morbidity and mortality rates associated with SARS-CoV-2 infection. Vaccines, especially mRNA vaccines, have been proposed in several studies to complicate viral myocarditis. Thus, our systematic and meta-analysis review aims to further investigate the possibility of an association between COVID-19 vaccines and myocarditis. We systematically searched PubMed, Web of Science, Scopus, Ovid, and Google Scholar and did a gray search of other databases using the following keywords and terms: "Myocarditis ("Myocarditis" Mesh) OR "Chagas Cardiomyopathy" Mesh) AND "COVID-19 Vaccines" Mesh. The studies were limited to only English articles that reported myocardial inflammation or myocarditis associated with COVID-19 vaccines. Pooled risk ratio with its 95% confidence interval was analyzed by RevMan software (5.4) to perform the meta-analysis. Our study included 671 patients from 44 studies with a mean age of 14-40 years. Nevertheless, myocarditis was noted in a mean of (3.227) days, and 4.19 per million vaccination recipients experienced myocarditis. Most cases were clinically presented with manifestations of cough, chest pain, and fever. Laboratory tests revealed increased C-reactive protein, and troponin with all other cardiac markers in most patients. Cardiac magnetic resonance imaging (MRI) revealed late gadolinium enhancement with myocardial edema and cardiomegaly. Also, electrocardiograms revealed ST-segment elevation in most patients. Furthermore, the incidence of myocarditis was statistically significantly lower in the COVID-19 vaccine group as compared with the control group (RR = 0.15, 95% CI = 0.10-0.23, p-value < 0.00001). No significant association was found between COVID-19 vaccines and the incidence of myocarditis. The study's findings highlight the importance of implementing evidence-based COVID-19 prevention strategies, such as vaccination, to reduce the public health impact of COVID-19 and its associated complications.
format Online
Article
Text
id pubmed-10203748
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher Cureus
record_format MEDLINE/PubMed
spelling pubmed-102037482023-05-23 Myocarditis Following COVID-19 Vaccination: A Systematic Review Shaheen, Nour Ramadan, Abdelraouf Shaheen, Ahmed Elmasry, Mohamed Swed, Sarya Hafez, Wael Wael, Muhannad Cureus Cardiology COVID-19 vaccination has significantly reduced both the morbidity and mortality rates associated with SARS-CoV-2 infection. Vaccines, especially mRNA vaccines, have been proposed in several studies to complicate viral myocarditis. Thus, our systematic and meta-analysis review aims to further investigate the possibility of an association between COVID-19 vaccines and myocarditis. We systematically searched PubMed, Web of Science, Scopus, Ovid, and Google Scholar and did a gray search of other databases using the following keywords and terms: "Myocarditis ("Myocarditis" Mesh) OR "Chagas Cardiomyopathy" Mesh) AND "COVID-19 Vaccines" Mesh. The studies were limited to only English articles that reported myocardial inflammation or myocarditis associated with COVID-19 vaccines. Pooled risk ratio with its 95% confidence interval was analyzed by RevMan software (5.4) to perform the meta-analysis. Our study included 671 patients from 44 studies with a mean age of 14-40 years. Nevertheless, myocarditis was noted in a mean of (3.227) days, and 4.19 per million vaccination recipients experienced myocarditis. Most cases were clinically presented with manifestations of cough, chest pain, and fever. Laboratory tests revealed increased C-reactive protein, and troponin with all other cardiac markers in most patients. Cardiac magnetic resonance imaging (MRI) revealed late gadolinium enhancement with myocardial edema and cardiomegaly. Also, electrocardiograms revealed ST-segment elevation in most patients. Furthermore, the incidence of myocarditis was statistically significantly lower in the COVID-19 vaccine group as compared with the control group (RR = 0.15, 95% CI = 0.10-0.23, p-value < 0.00001). No significant association was found between COVID-19 vaccines and the incidence of myocarditis. The study's findings highlight the importance of implementing evidence-based COVID-19 prevention strategies, such as vaccination, to reduce the public health impact of COVID-19 and its associated complications. Cureus 2023-04-22 /pmc/articles/PMC10203748/ /pubmed/37223162 http://dx.doi.org/10.7759/cureus.37999 Text en Copyright © 2023, Shaheen et al. https://creativecommons.org/licenses/by/3.0/This is an open access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
spellingShingle Cardiology
Shaheen, Nour
Ramadan, Abdelraouf
Shaheen, Ahmed
Elmasry, Mohamed
Swed, Sarya
Hafez, Wael
Wael, Muhannad
Myocarditis Following COVID-19 Vaccination: A Systematic Review
title Myocarditis Following COVID-19 Vaccination: A Systematic Review
title_full Myocarditis Following COVID-19 Vaccination: A Systematic Review
title_fullStr Myocarditis Following COVID-19 Vaccination: A Systematic Review
title_full_unstemmed Myocarditis Following COVID-19 Vaccination: A Systematic Review
title_short Myocarditis Following COVID-19 Vaccination: A Systematic Review
title_sort myocarditis following covid-19 vaccination: a systematic review
topic Cardiology
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10203748/
https://www.ncbi.nlm.nih.gov/pubmed/37223162
http://dx.doi.org/10.7759/cureus.37999
work_keys_str_mv AT shaheennour myocarditisfollowingcovid19vaccinationasystematicreview
AT ramadanabdelraouf myocarditisfollowingcovid19vaccinationasystematicreview
AT shaheenahmed myocarditisfollowingcovid19vaccinationasystematicreview
AT elmasrymohamed myocarditisfollowingcovid19vaccinationasystematicreview
AT swedsarya myocarditisfollowingcovid19vaccinationasystematicreview
AT hafezwael myocarditisfollowingcovid19vaccinationasystematicreview
AT waelmuhannad myocarditisfollowingcovid19vaccinationasystematicreview